Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanouil Papasavvas

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
AIDS (London, England)|July 18, 2020
Hepatitis C virus modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individualsLeila B Giron, Livio Azzoni, Xiangfan Yin, et al.
Ebiomedicine|August 23, 2020
Interferon-α alters host glycosylation machinery during treated HIV infectionLeila B Giron, Florent Colomb, Emmanouil Papasavvas, et al.
Nature Communications|June 30, 2021
Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIVLeila B Giron, Clovis S Palmer, Qin Liu, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2011
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesotheliomaDaniel H Sterman, Andrew Haas, Edmund Moon, et al.
Cancer Research Communications|May 7, 2025
PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural MesotheliomaGwendolyn M Cramer, Richard W Davis, Emmanouil Papasavvas, et al.
Blood|December 25, 2012
Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIVPablo Tebas, David Stein, Gwendolyn Binder-Scholl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with ChemotherapyDaniel H Sterman, Evan Alley, James P Stevenson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2021
Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral TherapyEmmanouil Papasavvas, Livio Azzoni, Brian N Ross, et al.
Signal Transduction and Targeted Therapy|October 2, 2025
Retinol Binding Protein 4 reactivates latent HIV-1 by triggering canonical NF-κB, JAK/STAT5 and JNK signallingChiara Pastorio, Khumoekae Richard, Shariq Usmani, et al.
Nature Communications|January 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studiesJesper D Gunst, Jesal Gohil, Johanthan Z Li, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|July 18, 2020
Hepatitis C virus modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individualsLeila B Giron, Livio Azzoni, Xiangfan Yin, et al.
Ebiomedicine|August 23, 2020
Interferon-α alters host glycosylation machinery during treated HIV infectionLeila B Giron, Florent Colomb, Emmanouil Papasavvas, et al.
Nature Communications|June 30, 2021
Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIVLeila B Giron, Clovis S Palmer, Qin Liu, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2011
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesotheliomaDaniel H Sterman, Andrew Haas, Edmund Moon, et al.
Cancer Research Communications|May 7, 2025
PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural MesotheliomaGwendolyn M Cramer, Richard W Davis, Emmanouil Papasavvas, et al.
Blood|December 25, 2012
Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIVPablo Tebas, David Stein, Gwendolyn Binder-Scholl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with ChemotherapyDaniel H Sterman, Evan Alley, James P Stevenson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2021
Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral TherapyEmmanouil Papasavvas, Livio Azzoni, Brian N Ross, et al.
Signal Transduction and Targeted Therapy|October 2, 2025
Retinol Binding Protein 4 reactivates latent HIV-1 by triggering canonical NF-κB, JAK/STAT5 and JNK signallingChiara Pastorio, Khumoekae Richard, Shariq Usmani, et al.
Nature Communications|January 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studiesJesper D Gunst, Jesal Gohil, Johanthan Z Li, et al.
Pageof 6